Results 101 to 110 of about 2,996 (188)
Severe congenital myasthenic syndromes caused by agrin mutations affecting secretion by motoneurons. [PDF]
Jacquier A +21 more
europepmc +1 more source
Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies [PDF]
Congenital myasthenic syndromes are associated with impairments in neuromuscular transmission. Belaya et al. show that mutations of the glycosylation pathway enzyme GMPPB, which has previously been implicated in muscular dystrophy dystroglycanopathy ...
Maxwell S +21 more
core
DOK7 congenital myasthenic syndrome: case series and review of literature
Background Congenital myasthenic syndromes (CMS) are among the most challenging differential diagnoses in the neuromuscular domain, consisting of diverse genotypes and phenotypes. A mutation in the Docking Protein 7 (Dok-7) is a common cause of CMS. DOK7
Bentolhoda Ziaadini +9 more
doaj +1 more source
Background Congenital Myasthenic Syndromes (CMS) are rare genetic diseases, which share as a common denominator muscle fatigability due to failure of neuromuscular transmission. A distinctive clinical feature of presynaptic CMS variants caused by defects
Javier A Muntadas +6 more
doaj +1 more source
Synaptic dysfunction in congenital myasthenic syndromes.
Congenital myasthenic syndromes (CMS) are hereditary disorders of neuromuscular transmission characterized by fatigable muscle weakness. The number of cases recognized is increasing with improved diagnosis.
David Beeson, Beeson, D, Beeson, David
core +1 more source
Diplopia Due to Congenital Myasthenic Syndrome Mimics Divergence Insufficiency
Congenital myasthenic syndromes (CMS) are a genotypically and phenotypically heterogeneous group of neuromuscular disorders from the impaired neuromuscular transmission.
Yan Yan, MD, PhD
core
Drug Therapy in Myasthenia Gravis and Congenital Myasthenic Syndromes
While surgical removal of the thymus gland or a thymoma is often part of the therapy of myasthenia gravis (MG), the mainstay of management for ocular MG remains drug therapy.
Preston C. Calvert
core
Eye Movement Characteristics of Congenital Myasthenic Syndromes
Congenital myasthenic syndromes (CMS) are a group of inherited disorders caused by gene variants leading to impaired transmission at the neuromuscular junction.1, 2 The gene CHRNE encodes the subunit of the pentameric acetylcholine receptor and ...
Ruben Jauregui; Nicolas Abreu; John-Ross Rizzo; Todd Hudson; Janet Rucker; Scott Grossman
core
Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy
International audienceCongenital myasthenic syndromes are a clinically and genetically heterogeneous group of rare diseases resulting from impaired neuromuscular transmission.
Chaouch, Amina +31 more
core +1 more source

